Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biliary Tract Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07726446
What this trial is testing

Study on Sequential Cryoablation, Relaforp Alpha, and Chemotherapy for Bile Duct Tumors

Who this might be right for
Biliary Tract Cancer (BTC)
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableLooking for participantsNCT06277531
What this trial is testing

Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE)

Who this might be right for
Biliary StrictureBile Duct CancerPancreas Cancer
Peking University Third Hospital 99
Testing effectiveness (Phase 2)UnknownNCT06074029
What this trial is testing

Exploratory Study on the Therapeutic Effect Prediction Model of Advanced BTC Immunotherapy

Who this might be right for
Biliary Tract CancerImmune Checkpoint InhibitorPredictive Cancer Model
Peking Union Medical College Hospital 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06730581
What this trial is testing

Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors

Who this might be right for
Gastric Cancer Adenocarcinoma MetastaticOvarian CancerBile Duct Cancer
Beijing Biostar Pharmaceuticals Co., Ltd. 100
Not applicableStudy completedNCT03708445
What this trial is testing

Development of a New Immunochemistry Method Using Antibodies of Proteins Related Bile Duct Cancer

Who this might be right for
Bile Duct Obstruction, Extrahepatic
Gangnam Severance Hospital 240
Testing effectiveness (Phase 2)Study completedNCT06111872
What this trial is testing

Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.

Who this might be right for
CholangitisPancreatic CancerCholedocholithiasis+1 more
National University of Malaysia 90
Testing effectiveness (Phase 2)Ended earlyNCT04683939
What this trial is testing

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors

Who this might be right for
Solid TumorGastric CancerGastroesophageal Junction Adenocarcinoma+5 more
BioNTech SE 13
Testing effectiveness (Phase 2)Study completedNCT03833661
What this trial is testing

M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)

Who this might be right for
Biliary Tract CancerCholangiocarcinomaGallbladder Cancer
EMD Serono Research & Development Institute, Inc. 159
Testing effectiveness (Phase 2)Active Not RecruitingNCT05994001
What this trial is testing

Candonilimab in Combination With LM-302 for Claudin 18.2 Positive-advanced Biliary Tract Cancer After Failure of Standard of Chemotherapy and PD1/PD-L1 Antibody

Who this might be right for
Biliary Tract CancerCandonilimabClaudin 18.2
Shanghai Zhongshan Hospital 78
Not applicableStudy completedNCT04250402
What this trial is testing

The Incidence of Gallstones After Gastric Cancer Surgery

Who this might be right for
GallstonesGastric Cancer
Hepatopancreatobiliary Surgery Institute of Gansu Province 1,019
Testing effectiveness (Phase 2)Study completedNCT02433639
What this trial is testing

Study of TH-302 Monotherapy as Second-line Treatment in Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Seoul National University Hospital 24
Not applicableUnknownNCT03788655
What this trial is testing

Metal Stents (Moving Cell Stent) for Inoperable Tumors of the Bile Duct Tract

Who this might be right for
Bile Duct StrictureBile Duct Cancer
Johannes Vermehren 30
Not applicableStudy completedNCT01673269
What this trial is testing

Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBD

Who this might be right for
CholedocholithiasisCholangiocarcinomaBenign Stricture of Common Bile Duct
Texas Tech University Health Sciences Center, El Paso 60
Testing effectiveness (Phase 2)UnknownNCT03144856
What this trial is testing

Apatinib as Second Line Therapy in Patients With Advanced Refractory Biliary Tract Cancers

Who this might be right for
Biliary Tract Cancer
Sun Yat-sen University 39
Not applicableEnded earlyNCT04561453
What this trial is testing

Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerCholangiocarcinomaGallbladder Cancer+5 more
University of Washington 14
Testing effectiveness (Phase 2)UnknownNCT04984980
What this trial is testing

Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab in Unresectable Biliary Tract Cancer

Who this might be right for
Biliary Tract CarcinomaInitially Unresectable
Fudan University 37
Testing effectiveness (Phase 2)Study completedNCT00660140
What this trial is testing

Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer

Who this might be right for
CholangiocarcinomaGallbladder Cancer
Washington University School of Medicine 49
Not applicableStudy completedNCT00489515
What this trial is testing

Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder

Who this might be right for
Colorectal CancerGallbladder CancerGastric Cancer+2 more
Wake Forest University Health Sciences 115
Early research (Phase 1)Ended earlyNCT04178460
What this trial is testing

Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment

Who this might be right for
Gastric CancerTriple Negative Breast CancerBiliary Tract Carcinoma+1 more
Zai Lab (Shanghai) Co., Ltd. 60
Testing effectiveness (Phase 2)Ended earlyNCT01855724
What this trial is testing

Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree Cancer

Who this might be right for
CholangiocarcinomaGallbladder CarcinomaBiliary Carcinoma
Hellenic Cooperative Oncology Group 29
Next Page